Market Tracker

03/03 6:53am ET

Enzo Biochem Inc (NYSE:ENZ)

3.07
Delayed Data
As of Mar 02
 +0.01 / +0.33%
Today’s Change
2.51
Today|||52-Week Range
6.13
-30.86%
Year-to-Date

Today’s Trading

Previous close3.06
Today’s open3.08
Day’s range2.99 - 3.11
Volume115,560
Average volume (3 months)210,095
Market cap$136.9M
Dividend yield--
Data as of 03/02/2015

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+2.39%
P/E ratioNM
Price/Sales1.97
Price/Book3.66

Competitors

 Today’s
change
Today’s
% change
CDXSCodexis Inc+0.17+4.82%
ONTYOncothyreon Inc+0.02+1.25%
PRTOProteon Therapeutics...-0.12-1.06%
--Mologen AG-1.62-12.62%
Data as of 03/02/2015

Financials

Next reporting dateMarch 10, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$95.9M
Annual profit (last year)-$10.0M
Net profit margin-10.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer, Director &
CAO
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts